deeptech Value proposition
[Automatic translation follows] Innovative Breast Cancer Research
SOLTI is a leading group in clinical cancer research in Spain. With a consolidated track record of more than 25 years, its main activity focuses on the design and execution of translational-based clinical studies within the academic field. Her interest has been focused on breast cancer, but she opens her scope to other tumors. SOLTI has accumulated experience of 80 clinical trials and more than 30 underway and is made up of 480 researchers in a network of 100 centers between Spain, Portugal and Ireland, coordinated by a central office in which a team of more than 60 people works. . SOLTI is part of the Spanish Society of Medical Oncology (SEOM) and is a non-profit association that, in addition to its scientific activity, has a Medical and Patient Education program with multiple annual initiatives. SOLTI's mission is to promote, from a disruptive vision, innovative research that improves the well-being and prognosis of cancer patients.
SOLTI focuses its efforts on developing cutting-edge clinical trials with novel targeted therapeutics including innovative translational research, fostering the participation of research into breast cancer in international networks and promoting excellence in the management of breast cancer among its members.
-----------------------------
SOLTI is an academic group dedicated to clinical research in oncology that develops clinical trials of excellence in breast cancer. It currently has more than 300 research partners, as well as an extensive network made up of more than 80 leading hospital centers in Spain, Portugal, France and Italy.
SOLTI focuses its efforts on developing cutting-edge clinical trials with anti-target agents, incorporating innovative translational research in all the projects in which it participates, and promoting excellence in the treatment of breast cancer.
clinical trials, breast cancer, oncology, translational research, clinical research, and targeted therapiesOriginal language
Innovative Breast Cancer Research
SOLTI es un grupo referente en investigación clínica del cáncer en España. Con una trayectoria consolidada de más de 25 años, su actividad principal se centra en el diseño y ejecución de estudios clínicos de base traslacional dentro del ámbito académico. Su interés se ha focalizado en cáncer de mama, pero abre su ámbito a otros tumores. SOLTI tiene una experiencia acumulada de 80 ensayos clínicos y más de 30 en marcha y está integrado por 480 investigadores en una red de 100 centros entre España, Portugal e Irlanda, coordinados por una oficina central en la que trabaja un equipo de más de 60 personas. SOLTI forma parte de la Sociedad Española de Oncología Médica (SEOM) y es una asociación sin ánimo de lucro que, además de su actividad científica, cuenta con un programa de Educación Médica y para pacientes con múltiples iniciativas anuales. La misión de SOLTI es promover, desde una visión disruptiva, una investigación innovadora que mejore el bienestar y el pronóstico de los pacientes con cáncer.
SOLTI focuses its efforts on developing cutting-edge clinical trials with novel targeted therapeutics including innovative translational research, fostering the participation of research into breast cancer in international networks and promoting excellence in the management of breast cancer among their members.
-----------------------------
SOLTI es un grupo académico dedicado a la investigación clínica en oncología que desarrolla ensayos clínicos de excelencia en cáncer de mama. Actualmente cuenta con más de 300 socios investigadores, así como una amplia red formada por más de 80 centros hospitalarios líderes en España, Portugal, Francia e Italia.
SOLTI centra sus esfuerzos en desarrollar ensayos clínicos de vanguardia con agentes contra diana, incorporar la investigación traslacional innovadora en todos los proyectos en los que participa y promover la excelencia en el tratamiento del cáncer de mama.
clinical trials, breast cancer, oncology, translational research, clinical research, and targeted therapies
SOLTI – Shaping the future of cancer research
En SOLTI, estamos dando forma al futuro de la investigación del cáncer a través de la investigación académica, clínica y traslacional, los ensayos clínicos . Únase a nosotros en nuestra misión de luchar contra el cáncer y marcar la diferencia.
https://www.gruposolti.org/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 Roche Pharmaceutical, Biotechnology, Biotechnology Research | Roche Pharmaceutical, Biotechnology, Biotechnology Research | Other 21 Jun 2023 | | |
 Pfizer Pharmaceutical, Pharmaceutical Manufacturing | Pfizer Pharmaceutical, Pharmaceutical Manufacturing | Other 25 Nov 2023 | | |
 Gilead Sciences Pharmaceutical, Biotechnology, Biotechnology Research | Gilead Sciences Pharmaceutical, Biotechnology, Biotechnology Research | Other 25 Nov 2023 | | |
 AstraZeneca Pharmaceutical, Pharmaceutical Manufacturing | AstraZeneca Pharmaceutical, Pharmaceutical Manufacturing | Other 25 Nov 2023 | | |
 Novartis Pharmaceutical, Pharmaceutical Manufacturing | Novartis Pharmaceutical, Pharmaceutical Manufacturing | Other 12 Jul 2023 | | |